Loading company
Curanex Pharmaceuticals Inc
CURX · Nasdaq · ·
$5.06-1.1%Sep 29 close
- 1M
- +12.6%
- 6M
- -50.4%
- 1Y
- -67.3%
CURX · Nasdaq · ·
$5.06-1.1%Sep 29 close
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Profit | -$3.3M | -$60.3K | -5,353.50% |
| Profit per share | -$0.12 | $0.00 | — |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Curanex Pharmaceuticals Inc has no earnings call transcript available.